Endpoints News 25. Nov. 2025 Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News 24. Nov. 2025 Kelun's TROP2 ADC plus Keytruda improves outcomes in first-line lung cancer #first-line lung #lung cancer
Endpoints News 21. Nov. 2025 FDA investigates child death potentially related to Takeda's enzyme replacement therapy #FDA investigates #blood disorder